https://www.bbc.co.uk/news/health-53467022

Double-blind Study
n=101
Groups matched on age and comorbidities
Odds of requiring ventilation reduced by 79% when on the treatment. p = .046
Treatment group was more than twice as likely to have been discharged by the end of treatment period. p=.062
By Day 28, treatment group was almost 4 times as likely to have recovered. p=.017

Inhaled form of interferon beta. New product and limited testing, so still a ways out.

But if the study holds up in bigger trial, big time breakthrough.

Thanks, OP! I truly appreciate this TA forum for scouring the internet, looking for the latest breaking news.

I hope this small study can be replicated and becomes a weapon in attacking COVID19 and any of its novel kin that comes along in the future. It is truly amazing to consider how many relatively small companies are using different vectors to attack this virus.